Cerence, Samsung settle; Cerence to receive $49,500,000 payment

Cerence Inc. announced a resolution of its patent disputes with Samsung through a cross‑license agreement.

Rhea-AI Filing Summary

Cerence Inc. announced a resolution of its patent disputes with Samsung through a cross‑license agreement. As part of the settlement, Samsung agreed to pay Cerence a one‑time lump sum of $49,500,000.

The agreement resolves two cases: “Samsung I,” filed October 13, 2023, and “Samsung II,” filed March 15, 2024. Samsung had asserted counterclaims in July 2024, and trials had been scheduled for October 2025 and April 2026. The cross‑license, reached on October 28, 2025, concludes the litigation path and provides Cerence with a defined cash inflow in place of uncertain trial outcomes.

Insights

IP licensing and litigation analyst

Settlement ends litigation and delivers a defined $49,500,000 cash inflow.

Cerence and Samsung entered a cross‑license on October 28, 2025, resolving two multi‑patent cases that were heading to trials. The agreement includes a one‑time payment of $49,500,000 to Cerence, replacing trial uncertainty with immediate value.

Cross‑licenses typically eliminate ongoing legal risk and potential future injunction or damages exposure. Here, scheduled trials in October 2025 and April 2026 are effectively mooted by the settlement terms disclosed.

Key considerations are the cash receipt mechanics and any ongoing license scope, which are not detailed in the excerpt. Subsequent filings may provide additional terms or timing.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

FAQ

What did CRNC announce regarding its disputes with Samsung?

Cerence and Samsung entered a cross‑license agreement that resolves their patent disputes, with Samsung agreeing to pay $49,500,000 to Cerence.

How much will Cerence (CRNC) receive under the settlement?

Samsung agreed to pay Cerence a one‑time lump sum of $49,500,000.

Which cases were resolved by the Cerence–Samsung cross‑license?

The agreement resolves “Samsung I” (filed October 13, 2023) and “Samsung II” (filed March 15, 2024).

What were the scheduled trial dates before the settlement?

Trials were scheduled for October 2025 (Samsung I) and April 2026 (Samsung II).

When was the cross‑license agreement reached?

The parties reached the agreement on October 28, 2025.

Did Samsung assert counterclaims against Cerence?

Yes. In July 2024, Samsung asserted counterclaims alleging infringement of several U.S. patents and sought damages and fees.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/03/2025 - 07:58 AM Learn about SEC filing dates

0001768267FALSE00017682672025-10-282025-10-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

________________________________________________________

FORM 8-K

________________________________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 28, 2025

________________________________________________________

CERENCE INC.

(Exact name of Registrant as Specified in Its Charter)

________________________________________________________

Delaware

001-39030

83-4177087

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

25 Mall Road, Suite 416 Burlington, Massachusetts

01803

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (857)362-7300

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

________________________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐						Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐						Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐						Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐						Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.01 par value

CRNC

The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 8.01 Other Events.

On October 13, 2023, Cerence Operating Company (hereinafter referred to as “Cerence”) filed its first patent infringement complaint against Samsung Electronics Co. Ltd. and Samsung Electronics America, Inc. (hereinafter collectively referred to as “Samsung”) alleging infringement of five Cerence patents (hereinafter referred to as “Samsung I”). On March 15, 2024, Cerence filed its second patent infringement complaint against Samsung alleging infringement of four additional Cerence patents (hereinafter referred to as “Samsung II”). In its responsive pleading to Samsung II, on July 10, 2024, Samsung asserted counterclaims, alleging infringement of U.S. Patent Nos. 10,395,657; 10,720,162; 11,823,682; and 9,583,103 against the Cerence Assistant. Samsung sought damages, including trebled damages, and its costs and fees. On September 4, 2024, Cerence filed its answer denying the allegations and counterclaims of invalidity and noninfringement. Trial for Samsung I was scheduled to begin in October 2025 and trial for Samsung II was scheduled to begin in April 2026. On October 28, 2025 Samsung and Cerence resolved these disputes by entering into a cross-license agreement, which, among other things, resulted in Samsung agreeing to pay Cerence a one-time lump sum payment in the total amount of Forty Nine Million Five Hundred Thousand Dollars ($49,500,000).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			Cerence Inc.
Date: November 3, 2025			By:			/s/ Jennifer Salinas
						Name: Jennifer Salinas
						Title: Executive Vice President, Chief Administrative Officer & General Counsel